U.S. TB Incidence Increased in 2022, With Ongoing Racial and Ethnic Disparities
Why is tuberculosis rising again in the United States?
A U.S. surveillance report indicates an increase in tuberculosis incidence during 2022. The report also notes ongoing disparities in TB inci…
Tuberculosis cases rose again in the United States in 2022, and the problem continues to hit certain racial and ethnic communities hardest.
Surveillance report updates tuberculosis elimination progress and program performance in the United States from 2016 to 2022
How is the U.S. doing in its fight against tuberculosis?
A surveillance report provides an update on progress toward tuberculosis elimination and tuberculosis program performance in the United Stat…
A new report updates progress on eliminating tuberculosis in the United States from 2016 to 2022, showing how the fight is going.
Tuberculosis Cases Increased in the United States During 2023
Tuberculosis Cases Increased in the United States During 2023
A report indicates tuberculosis cases increased in the United States across all age groups in 2023. The specific magnitude of increase, stud…
Tuberculosis cases in the United States increased during 2023 across all age groups, signaling a trend public health officials are monitorin…
CureTB program evaluated continuity of care for tuberculosis patients relocating internationally
Program evaluated continuity of care for tuberculosis patients moving between countries
A program evaluation assessed the CureTB continuity of care initiative for tuberculosis patients relocating to other countries from 2016-202…
The CureTB program helped tuberculosis patients keep their treatment going when moving between countries from 2016 to 2023.
CDC recommends approaches to maintain tuberculin skin testing during expected Aplisol shortage
CDC issues guidance during expected shortage of tuberculosis skin test antigen
The CDC has issued recommendations for maintaining tuberculin skin testing capability during an expected shortage of Aplisol. The publicatio…
Health officials warn of an expected shortage of Aplisol, a key ingredient for tuberculosis skin tests, and are releasing guidance to keep c…
Potential drug interactions did not affect rifampin TB prevention completion or adverse events
Do drug interactions make tuberculosis prevention harder to finish?
A secondary analysis of 1368 participants in a rifampin TPT trial found no difference in treatment completion or adverse events between thos…
Tuberculosis prevention treatment works safely with other drugs, but patients taking them face more unscheduled doctor visits during the cou…